新华鲜报丨再拓新领域！新一批医用耗材“团购清单”亮相

Core Insights - The sixth batch of national organized high-value medical consumables centralized procurement has been announced, covering 12 types of medical consumables in two categories: drug-coated balloons and urological intervention, with 202 companies and 440 products selected [1][5]. Group 1: Urological Consumables - For the first time, consumables related to urological stone surgery have been included in the centralized procurement, covering essential items such as ureteral intervention guidewires and balloons, with 170 companies and 398 products selected [3]. - This inclusion is expected to significantly reduce the overall treatment costs for stone diseases, which previously ranged from 20,000 to 30,000 yuan per procedure [3]. Group 2: Drug-Coated Balloons - The procurement now includes drug-coated balloons, expanding the coverage of cardiovascular intervention consumables, which previously included only coronary and peripheral vascular stents [5]. - The inclusion of drug-coated balloons is anticipated to benefit more patients, particularly those experiencing restenosis after stent placement [5]. Group 3: Procurement Strategy - The procurement process emphasizes a "反内卷" (anti-involution) principle, ensuring that clinically recognized and capable products are selected while preventing malicious low pricing [5][6]. - A pricing mechanism has been established to avoid excessively low bids, using the average price of selected products as a baseline for price differences [6]. - The national medical insurance department has successfully procured 142 types of medical consumables across nine categories, with the implementation expected around May 2026 [6].